Atlas Trials

Using Genetic Polymorphisms to Predict the Efficacy and Toxicity - A Gastric Adenocarcinoma Study

Clinical trial NCT01558011 · TERMINATED

Trial details

NCT number
NCT01558011
Sponsor
National Health Research Institutes, Taiwan
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric Adenocarcinoma
Start date
2012-03-01
Primary completion
2014-10-01
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.